Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial

Pieter F. van der Meer, Paula F. Ypma, Nan van Geloven, Joost A. van Hilten, Rinie J. van Wordragen-Vlaswinkel, Okke Eissen, Jaap J. Zwaginga, Michael Trus, Erik A. M. Beckers, Peter te Boekhorst, Alan Tinmouth, Yulia Lin, Cyrus Hsia, David Lee, Philip J. Norris, Raymond P. Goodrich, Anneke Brand, Tor Hervig, Nancy M. Heddle, Johanna G. van der BomJean-Louis H. Kerkhoffs

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)223-231
Number of pages9
JournalBlood
Volume132
Issue number2
DOIs
Publication statusPublished - 12 Jul 2018

Keywords

  • WAVELENGTH ULTRAVIOLET-LIGHT
  • BLOOD-CELL INACTIVATION
  • PHOTOCHEMICAL TREATMENT
  • ADDITIVE SOLUTION
  • CLINICAL EFFECTIVENESS
  • RIBOFLAVIN
  • REDUCTION
  • AMOTOSALEN
  • TRANSFUSION
  • BACTERIA

Cite this

van der Meer, P. F., Ypma, P. F., van Geloven, N., van Hilten, J. A., van Wordragen-Vlaswinkel, R. J., Eissen, O., Zwaginga, J. J., Trus, M., Beckers, E. A. M., te Boekhorst, P., Tinmouth, A., Lin, Y., Hsia, C., Lee, D., Norris, P. J., Goodrich, R. P., Brand, A., Hervig, T., Heddle, N. M., ... Kerkhoffs, J-L. H. (2018). Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial. Blood, 132(2), 223-231. https://doi.org/10.1182/blood-2018-02-831289